首頁 > 市場調查報告書 > 製藥

精神疾病

睡眠障礙市場規模、佔有率和成長分析（按疾病類型、產品類型、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904890

睡眠障礙市場規模、佔有率和成長分析（按疾病類型、產品類型、最終用途和地區分類）－2026-2033年產業預測

Sleep Disorder Market Size, Share, and Growth Analysis, By Disorder Type (Insomnia, Sleep Apnea), By Product (Diagnostics, Therapeutics), By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，睡眠障礙市場規模將達到 303.9 億美元，到 2025 年將達到 334.6 億美元，到 2033 年將達到 722.4 億美元，在預測期（2026-2033 年）內，複合年成長率為 10.1%。

全球睡眠障礙市場專注於診斷、治療和管理影響睡眠品質和時長的各種疾病。由於人們越來越意識到睡眠在整體健康中的重要作用，該市場正經歷顯著成長。失眠、睡眠呼吸中止症和不寧腿症候群等疾病的需求最為旺盛，這主要受生活方式改變、壓力增加以及睡眠相關健康問題增加的推動。科技進步正在拓展診斷和治療選擇，包括創新的穿戴式裝置和遠端醫療。人口老化以及肥胖和糖尿病等慢性疾病發病率的上升（這些疾病會加劇睡眠障礙）進一步推動了市場擴張。整體而言，人們正在持續增加對研發的投入，以期為面臨睡眠挑戰的人們提供有效的干涉措施。

睡眠障礙市場促進因素

人們對睡眠障礙相關不良健康影響的認知不斷提高，是推動市場發展的關鍵因素。隨著教育的活性化和資訊在各種平台上的共用，越來越多的人意識到解決睡眠相關問題的重要性。這種認知的轉變促使人們更加重視正確的診斷和治療方法方案，從而推動了睡眠障礙解決方案市場需求的成長。持續不斷的關於身心健康的討論進一步凸顯了有效干預措施的緊迫性，促使人們更加關注睡眠障礙的管理以及改善患者的整體健康狀況。

睡眠障礙市場的限制

由於社會上根深蒂固的對睡眠障礙的歧視，睡眠障礙市場面臨著巨大的限制，這往往阻礙了人們尋求所需的專業協助。此外，不同地區對睡眠障礙的性質和嚴重程度缺乏了解，也妨礙了及時診斷和適當治療。因此，許多人可能默默忍受這些疾病的折磨，錯失了能夠顯著改善其生活品質的有效干預措施。這種社會歧視，加上區域知識水平的差距，對市場成長和睡眠障礙患者獲得醫療服務的可近性構成了挑戰。

睡眠障礙市場趨勢

睡眠障礙市場正呈現出顯著的遠端醫療和遠距監測趨勢，這反映了醫療服務模式的廣泛變化。由於科技進步，患者越來越希望在家中舒適便捷地接受睡眠障礙的診斷和治療。虛擬睡眠診所和用於遠端監測的穿戴式裝置正逐漸成為主流，提供即時數據和個人化治療方案。這種發展不僅改善了病患的就醫途徑，也提高了醫療專業人員的工作效率。隨著對靈活醫療解決方案的需求不斷成長，將數位健康工具整合到睡眠障礙管理中有望革新傳統方法，使消費者和醫療服務提供者都能從中受益。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Merck & Co., Inc.（USA）
Mylan NV（USA）
Pfizer Inc.（USA）
Takeda Pharmaceutical Company Limited（Japan）
Teva Pharmaceutical Industries Ltd.（Israel）
Jazz Pharmaceuticals plc（Ireland）
Sanofi（France）
GlaxoSmithKline plc（UK）
Eli Lilly and Company（USA）
Becton, Dickinson and Company（USA）
Koninklijke Philips NV（Netherlands）
ResMed Inc.（USA）
Fisher & Paykel Healthcare Corporation Limited（New Zealand）
Natus Medical Incorporated（USA）
Compumedics Limited（Australia）
Vyaire Medical, Inc.（USA）
SomnoMed Limited（Australia）
Drive DeVilbiss Healthcare（USA）
Cadwell Industries, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2156

Sleep Disorder Market size was valued at USD 30.39 Billion in 2024 and is poised to grow from USD 33.46 Billion in 2025 to USD 72.24 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global Sleep Disorder Market focuses on the diagnosis, treatment, and management of various conditions that affect sleep quality and duration. As awareness of sleep's crucial role in overall health increases, the market is experiencing notable growth. Conditions like insomnia, sleep apnea, and restless legs syndrome are at the forefront of this demand, driven by changing lifestyles, heightened stress, and rising sleep-related health issues. Technological advancements are enhancing diagnostic and treatment options, including innovative wearable devices and telemedicine. The aging population, along with the rising rates of obesity and chronic conditions such as diabetes that exacerbate sleep disorders, further accelerates the market expansion. Overall, there is a sustained investment in research and development to provide effective interventions for those facing sleep challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sleep Disorder market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sleep Disorder Market Segments Analysis

Global Sleep Disorder Market is segmented by Disorder Type, Product, End-use and region. Based on Disorder Type, the market is segmented into Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy and Circadian Rhythm Disorders. Based on Product, the market is segmented into Diagnostics and Therapeutics. Based on End-use, the market is segmented into Hospitals & Sleep Laboratories and Home Care Settings & Individuals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sleep Disorder Market

The heightened awareness surrounding the negative health consequences associated with sleep disorders serves as a significant catalyst for the market. As education and information sharing intensify across multiple platforms, more individuals are recognizing the importance of addressing their sleep-related problems. This shift in understanding encourages people to pursue proper diagnosis and treatment options, thereby fostering a growing demand for solutions in the sleep disorder market. The ongoing dialogue about mental and physical well-being further amplifies the urgency for effective interventions, leading to a greater emphasis on managing sleep disorders and improving overall health outcomes in affected populations.

Restraints in the Sleep Disorder Market

The sleep disorder market faces notable restraints due to persistent stigma surrounding these conditions, which often prevents individuals from pursuing necessary professional assistance. Furthermore, in various regions, a lack of awareness regarding the nature and severity of sleep disorders hampers timely diagnosis and appropriate treatment. As a result, many individuals may endure these disorders in silence, missing out on effective interventions that could significantly improve their quality of life. This combination of societal stigma and regional knowledge gaps poses challenges for market growth and the accessibility of care for those affected by sleep-related issues.

Market Trends of the Sleep Disorder Market

The Sleep Disorder market is witnessing a significant trend towards telemedicine and remote monitoring, reflecting a broader shift in healthcare delivery. Patients increasingly prefer the convenience of receiving sleep disorder diagnosis and treatment from home, facilitated by advancements in technology. Virtual sleep clinics and wearable devices for remote monitoring are becoming mainstream, offering real-time data and personalized treatment plans. This evolution not only enhances accessibility for patients but also optimizes clinician efficiency. As the demand for flexible healthcare solutions grows, the integration of digital health tools in sleep disorder management is expected to transform traditional approaches, benefiting both consumers and providers.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Sleep Disorder Market Size by Disorder Type & CAGR (2026-2033)

Market Overview
Insomnia
Sleep Apnea
Restless Legs Syndrome
Narcolepsy
Circadian Rhythm Disorders

Global Sleep Disorder Market Size by Product & CAGR (2026-2033)

Market Overview
Diagnostics
Therapeutics

Global Sleep Disorder Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals & Sleep Laboratories
Home Care Settings & Individuals

Global Sleep Disorder Market Size & CAGR (2026-2033)

North America (Disorder Type, Product, End-use)
- US
- Canada
Europe (Disorder Type, Product, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Disorder Type, Product, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Disorder Type, Product, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Disorder Type, Product, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jazz Pharmaceuticals plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fisher & Paykel Healthcare Corporation Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Compumedics Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vyaire Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SomnoMed Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drive DeVilbiss Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cadwell Industries, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments